Literature DB >> 9449740

FLAIR and HASTE imaging in neurologic diseases.

S L Greenspan1, V P Mathews, K S Caldemeyer, M R Patel.   

Abstract

The need to develop faster imaging techniques has led to the implementation of fast spin-echo imaging, EPI, and hybrid imaging techniques. This article discusses two of these faster imaging techniques, fast fluid-attenuated inversion-recovery (FLAIR) imaging and half-Fourier acquisition single-shot turbo spin-echo (HASTE) imaging, and their potential clinical application in neurologic diseases. FLAIR imaging, in particular, has demonstrated considerable promise for the evaluation of intracranial pathology. HASTE imaging can be used for rapid imaging of the brain or spine in those patients who are claustrophobic or who have difficulty remaining still, but it does not yet have a primary role in clinical neuroradiology.

Entities:  

Mesh:

Year:  1998        PMID: 9449740

Source DB:  PubMed          Journal:  Magn Reson Imaging Clin N Am        ISSN: 1064-9689            Impact factor:   2.266


  4 in total

1.  MR imaging of leptomeningeal metastases: comparison of three sequences.

Authors:  Sanjay K Singh; Norman E Leeds; Lawrence E Ginsberg
Journal:  AJNR Am J Neuroradiol       Date:  2002-05       Impact factor: 3.825

2.  Intracranial meningeal disease: comparison of contrast-enhanced MR imaging with fluid-attenuated inversion recovery and fat-suppressed T1-weighted sequences.

Authors:  Waneerat Galassi; Warinthorn Phuttharak; John R Hesselink; John F Healy; Rosalind B Dietrich; Steven G Imbesi
Journal:  AJNR Am J Neuroradiol       Date:  2005-03       Impact factor: 3.825

3.  Diagnostic value of contrast-enhanced fluid-attenuated inversion recovery MR imaging of intracranial metastases.

Authors:  Nil Ercan; Serap Gultekin; Halil Celik; Turgut E Tali; Yusuf A Oner; Gonca Erbas
Journal:  AJNR Am J Neuroradiol       Date:  2004-05       Impact factor: 3.825

4.  Clinical Utility of a Novel Ultrafast T2-Weighted Sequence for Spine Imaging.

Authors:  M B Keerthivasan; B Winegar; J L Becker; A Bilgin; M I Altbach; M Saranathan
Journal:  AJNR Am J Neuroradiol       Date:  2018-07-12       Impact factor: 3.825

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.